1,110
Views
80
CrossRef citations to date
0
Altmetric
Poison Centre Research

Intoxications involving acrylfentanyl and other novel designer fentanyls – results from the Swedish STRIDA project

, , &
Pages 589-599 | Received 02 Dec 2016, Accepted 28 Feb 2017, Published online: 28 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Valérie Proulx & Benoit Tousignant. (2021) Drugs of abuse and ocular effects. Clinical and Experimental Optometry 104:5, pages 567-578.
Read now
Dieter Müller, Hartmud Neurath, Merja A. Neukamm, Maurice Wilde, Caroline Despicht, Sabine Blaschke & Marcel Grapp. (2019) New synthetic opioid cyclopropylfentanyl together with other novel synthetic opioids in respiratory insufficient comatose patients detected by toxicological analysis. Clinical Toxicology 57:9, pages 806-812.
Read now
Inês Tabarra, Sofia Soares, Tiago Rosado, Joana Gonçalves, Ângelo Luís, Sara Malaca, Mário Barroso, Thomas Keller, José Restolho & Eugenia Gallardo. (2019) Novel synthetic opioids – toxicological aspects and analysis. Forensic Sciences Research 4:2, pages 111-140.
Read now
Olaf H. Drummer. (2019) Fatalities caused by novel opioids: a review. Forensic Sciences Research 4:2, pages 95-110.
Read now

Articles from other publishers (75)

Rebekka Syrjanen, Jennifer L. Schumann, Tom Lyons, Ginny McKinnon, Sarah E. Hodgson, Rachelle Abouchedid, Dimitri Gerostamoulos, Zeff Koutsogiannis, John Fitzgerald & Shaun L. Greene. (2023) A risk-based approach to community illicit drug toxicosurveillance: operationalisation of the Emerging Drugs Network of Australia – Victoria (EDNAV) project. International Journal of Drug Policy 122, pages 104251.
Crossref
Maja Bergerhoff & Bjoern Moosmann. (2023) Novel Receptor-Binding-Based Assay for the Detection of Opioids in Human Urine Samples. Analytical Chemistry 95:5, pages 2723-2731.
Crossref
Chinaza Godswill Awuchi, Maduabuchi Patrick Aja, Nancy Bonareri Mitaki, Sonia Morya, Ikechukwu O. Amagwula, Chinelo Kate Echeta & Victory S. Igwe. (2023) New Psychoactive Substances: Major Groups, Laboratory Testing Challenges, Public Health Concerns, and Community-Based Solutions. Journal of Chemistry 2023, pages 1-36.
Crossref
Hallvard Gjerde, Anne Line Bretteville-Jensen, Lihn Bache-Andreassen, Kristin Hanoa, Håvard Furuhaugen, Gerd-Wenche Brochmann & Vigdis Vindenes. (2021) Which illicit drugs are injected in Oslo? A study based on analysis of drug residues in used injection equipment and self-reported information. Scandinavian Journal of Public Health 51:1, pages 21-27.
Crossref
Sabrine Bilel, Arianna Giorgetti, Micaela Tirri, Raffaella Arfè, Virginia Cristofori, Beatrice Marchetti, Giorgia Corli, Lorenzo Caruso, Giorgio Zauli, Raffaele Giorgetti & Matteo Marti. (2023) Sensorimotor Alterations Induced by Novel Fentanyl Analogs in Mice: Possible Impact on Human Driving Performances. Current Neuropharmacology 21:1, pages 87-104.
Crossref
Donna M. Papsun, Alex J. Krotulski & Barry K. Logan. (2022) Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances. American Journal of Forensic Medicine & Pathology 43:4, pages 315-327.
Crossref
Amanda L A Mohr, Barry K Logan, Melissa F Fogarty, Alex J Krotulski, Donna M Papsun, Sherri L Kacinko, Marilyn A Huestis & Jeri D Ropero-Miller. (2022) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review. Journal of Analytical Toxicology 46:6, pages e116-e185.
Crossref
Sabrine Bilel, Joaquim Azevedo Neto, Raffaella Arfè, Micaela Tirri, Rosa Maria Gaudio, Anna Fantinati, Tatiana Bernardi, Federica Boccuto, Beatrice Marchetti, Giorgia Corli, Giovanni Serpelloni, Fabio De-Giorgio, Davide Malfacini, Claudio Trapella, Girolamo Calo’ & Matteo Marti. (2022) In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl. Neuropharmacology 209, pages 109020.
Crossref
Judith Rodriguez Salas, Alex J Krotulski, Reta Newman, Jon R Thogmartin, Amanda L A Mohr & Barry K Logan. (2022) Concentrations of para -Fluorofuranylfentanyl in Paired Central and Peripheral Blood Collected during Postmortem Death Investigations . Journal of Analytical Toxicology 46:4, pages 358-373.
Crossref
Ana Y. Simão, Mónica Antunes, Emanuel Cabral, Patrik Oliveira, Luana M. Rosendo, Ana Teresa Brinca, Estefânia Alves, Hernâni Marques, Tiago Rosado, Luís A. Passarinha, Maristela Andraus, Mário Barroso & Eugenia Gallardo. (2022) An Update on the Implications of New Psychoactive Substances in Public Health. International Journal of Environmental Research and Public Health 19:8, pages 4869.
Crossref
Phillip Koshute, Nathan Hagan & N. Jordan Jameson. (2022) Machine learning model for detecting fentanyl analogs from mass spectra. Forensic Chemistry 27, pages 100379.
Crossref
Marcin Zawadzki, Olga Wachełko, Kaja Tusiewicz & Paweł Szpot. (2022) Severe poisoning after smoking a mixture of 4-fluoroisobutyryl fentanyl (4-FiBF) and alpha-pyrolidinoisohexaphenone (α-PiHP). Journal of Forensic and Legal Medicine 85, pages 102287.
Crossref
John R.H. Archer. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 131 156 .
Christopher Yates & Piotr M. Kabata. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 181 202 .
Piotr Adamowicz & Karolina Nowak. (2021) Blood concentrations of new synthetic opioids. International Journal of Legal Medicine 136:1, pages 107-122.
Crossref
David Vearrier & Oliver Grundmann. (2021) Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids. The Journal of Clinical Pharmacology 61:S2.
Crossref
Marcin Zawadzki, Olga Wachełko, Agnieszka Chłopaś-Konowałek & Paweł Szpot. (2021) Quantification and distribution of 4-fluoroisobutyryl fentanyl (4-FiBF) in postmortem biological samples using UHPLC–QqQ-MS/MS. Forensic Toxicology 39:2, pages 451-463.
Crossref
Nicolas Gilbert, Ryan E. Mewis & Oliver B. Sutcliffe. (2021) Fast & fluorinated – Development and validation of a rapid benchtop NMR approach and other routine screening methods for the detection and quantification of synthesized fluorofentanyl derivatives. Forensic Chemistry 23, pages 100321.
Crossref
Ralph Foglia, Anna Kline & Nina A. Cooperman. (2021) New and Emerging Opioid Overdose Risk Factors. Current Addiction Reports 8:2, pages 319-329.
Crossref
Vera Lukić, Ružica Micić, Biljana Arsić, Bojan Nedović & Živana Radosavljević. (2021) Overview of the major classes of new psychoactive substances, psychoactive effects, analytical determination and conformational analysis of selected illegal drugs. Open Chemistry 19:1, pages 60-106.
Crossref
Kim Moeller, Bengt Svensson & Rasmus Munksgaard. (2021) Fentanyl analogs on the Swedish webforum flashback: Interest and impact of scheduling. International Journal of Drug Policy 87, pages 103013.
Crossref
Christopher A. Blackwood & Jean Lud Cadet. (2021) The molecular neurobiology and neuropathology of opioid use disorder. Current Research in Neurobiology 2, pages 100023.
Crossref
Anna Åstrand, Svante Vikingsson, Ingrid Jakobsen, Niclas Björn, Robert Kronstrand & Henrik Gréen. (2020) Activation of the μ‐opioid receptor by alicyclic fentanyls: Changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure. Drug Testing and Analysis 13:1, pages 169-174.
Crossref
Bruno Mégarbane, Mathieu Oberlin, Jean-Claude Alvarez, Frederic Balen, Sébastien Beaune, Régis Bédry, Anthony Chauvin, Isabelle Claudet, Vincent Danel, Guillaume Debaty, Arnaud Delahaye, Nicolas Deye, Jean-Michel Gaulier, Francis Grossenbacher, Philippe Hantson, Frédéric Jacobs, Karim Jaffal, Magali Labadie, Laurence Labat, Jérôme Langrand, Frédéric Lapostolle, Philippe Le Conte, Maxime Maignan, Patrick Nisse, Philippe Sauder, Christine Tournoud, Dominique Vodovar, Sebastian Voicu, Pierre-Géraud Claret & Charles Cerf. (2020) Management of pharmaceutical and recreational drug poisoning. Annals of Intensive Care 10:1.
Crossref
Robert J. Flanagan, Eva Cuypers, Hans H. Maurer & Robin Whelpton. 2020. Fundamentals of Analytical Toxicology. Fundamentals of Analytical Toxicology 527 586 .
Justine Pardi, Allison Toriello & Gail Cooper. (2020) Evaluation of 4-fluoroisobutyrylfentanyl in blood samples from 247 authentic cases submitted to the New York City Office of Chief Medical Examiner in 2017–2018. Forensic Toxicology 38:2, pages 340-351.
Crossref
Tanja M. Gampfer, Lea Wagmann, Yu Mi Park, Annelies Cannaert, Jennifer Herrmann, Svenja Fischmann, Folker Westphal, Rolf Müller, Christophe P. Stove & Markus R. Meyer. (2020) Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine. Archives of Toxicology 94:6, pages 2009-2025.
Crossref
Anders Helander, Matilda Bäckberg & Olof Beck. (2020) Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project. PLOS ONE 15:4, pages e0232038.
Crossref
Tanja M Gampfer, Lea Wagmann, Matthias J Richter, Svenja Fischmann, Folker Westphal & Markus R Meyer. (2020) Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-Fentanyl. Journal of Analytical Toxicology 44:5, pages 449-460.
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Maurice Wilde, Michaela J. Sommer, Volker Auwärter & Maren Hermanns-Clausen. (2020) Acute severe intoxication with cyclopropylfentanyl, a novel synthetic opioid. Toxicology Letters 320, pages 109-112.
Crossref
Abu Shafi, Alex J. Berry, Harry Sumnall, David M. Wood & Derek K. Tracy. (2020) New psychoactive substances: a review and updates. Therapeutic Advances in Psychopharmacology 10, pages 204512532096719.
Crossref
Wing-sum Chan, George Fai Wong, Chi-wai Hung, Yau-nga Wong, Kit-mai Fung, Wai-kit Lee, Kwok-Leung Dao, Chung-wing Leung, Kam-moon Lo, Wing-man Lee & Bobbie Kwok-keung Cheung. (2020) Interpol review of toxicology 2016–2019. Forensic Science International: Synergy 2, pages 563-607.
Crossref
Sophie Salle, Sandra Bodeau, Alice Dhersin, Mathilde Ferdonnet, Ruben Goncalves, Marie Lenski, Benjamin Lima, Marie Martin, Jonathan Outreville, Jules Vaucel & Nicolas Fabresse. (2019) Novel synthetic opioids: A review of the literature. Toxicologie Analytique et Clinique 31:4, pages 298-316.
Crossref
Marco Pravetoni & Sandra D. Comer. (2019) Development of vaccines to treat opioid use disorders and reduce incidence of overdose. Neuropharmacology 158, pages 107662.
Crossref
Laurent Karila, Maude Marillier, Boris Chaumette, Joel Billieux, Nicolas Franchitto & Amine Benyamina. (2019) New synthetic opioids: Part of a new addiction landscape. Neuroscience & Biobehavioral Reviews 106, pages 133-140.
Crossref
Alexander Dinh Le & Saeed Khaled Alzghari. (2019) Systematic review of the clinical consequences of butyrfentanyl and corresponding analogues. Interdisciplinary Toxicology 12:2, pages 83-88.
Crossref
Neil B. Varshneya, D. Matthew Walentiny, Lea T. Moisa, Teneille D. Walker, Luli R. Akinfiresoye & Patrick M. Beardsley. (2019) Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances. Neuropharmacology 151, pages 171-179.
Crossref
Joshua Klingberg, Adam Cawley, Ronald Shimmon & Shanlin Fu. (2019) Collision-Induced Dissociation Studies of Synthetic Opioids for Non-targeted Analysis. Frontiers in Chemistry 7.
Crossref
Kaitlyn B. Palmquist & Madeleine J. Swortwood. (2019) Data-independent screening method for 14 fentanyl analogs in whole blood and oral fluid using LC-QTOF-MS. Forensic Science International 297, pages 189-197.
Crossref
Fabrizio Schifano, Stefania Chiappini, John Martin Corkery & Amira Guirguis. (2019) Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems. Frontiers in Pharmacology 10.
Crossref
Paul J Jannetto, Anders Helander, Uttam Garg, Gregory C Janis, Bruce Goldberger & Hemamalini Ketha. (2019) The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union. Clinical Chemistry 65:2, pages 242-253.
Crossref
Barbara Lovrecic, Mercedes Lovrecic, Branko Gabrovec, Marco Carli, Matteo Pacini, Angelo G. I. Maremmani & Icro Maremmani. (2019) Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health. International Journal of Environmental Research and Public Health 16:2, pages 177.
Crossref
Tatsuyuki Kanamori, Yuko T. Iwata, Hiroki Segawa, Tadashi Yamamuro, Kenji Kuwayama, Kenji Tsujikawa & Hiroyuki Inoue. (2019) Characterization and differentiation of positional isomers of fluoro-fentanyl analogs by a combination of instrumental analyses各種機器分析によるフルオロ-フェンタニル類の位置異性体識別. Japanese Journal of Forensic Science and Technology 24:2, pages 123-133.
Crossref
Nicholas C. Peiper, Sarah Duhart Clarke, Louise B. Vincent, Dan Ciccarone, Alex H. Kral & Jon E. Zibbell. (2019) Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. International Journal of Drug Policy 63, pages 122-128.
Crossref
Olof Beck, Alexia Rylski & Niclas Nikolai Stephanson. 2019. Critical Issues in Alcohol and Drugs of Abuse Testing. Critical Issues in Alcohol and Drugs of Abuse Testing 321 332 .
Anna Åstrand, Amanda Töreskog, Shimpei Watanabe, Robert Kronstrand, Henrik Gréen & Svante Vikingsson. (2018) Correlations between metabolism and structural elements of the alicyclic fentanyl analogs cyclopropyl fentanyl, cyclobutyl fentanyl, cyclopentyl fentanyl, cyclohexyl fentanyl and 2,2,3,3-tetramethylcyclopropyl fentanyl studied by human hepatocytes and LC-QTOF-MS. Archives of Toxicology 93:1, pages 95-106.
Crossref
Jessica Welter‐Luedeke & Hans H. Maurer. (2018) Relevance of published blood concentrations of new psychoactive substance for rational case interpretation. WIREs Forensic Science 1:1.
Crossref
Marianne Skov-Skov Bergh, Inger Lise BogenSteven Ray Wilson & Åse Marit Leere Øiestad. (2018) Addressing the Fentanyl Analogue Epidemic by Multiplex UHPLC-MS/MS Analysis of Whole Blood. Therapeutic Drug Monitoring 40:6, pages 738-748.
Crossref
Federico Baruffaldi, April Huseby Kelcher, Megan Laudenbach, Valeria Gradinati, Ajinkya Limkar, Michaela Roslawski, Angela Birnbaum, Andrew Lees, Carla Hassler, Scott Runyon & Marco Pravetoni. (2018) Preclinical Efficacy and Characterization of Candidate Vaccines for Treatment of Opioid Use Disorders Using Clinically Viable Carrier Proteins. Molecular Pharmaceutics 15:11, pages 4947-4962.
Crossref
Paolo Frisoni, Erica Bacchio, Sabrine Bilel, Anna Talarico, Rosa Gaudio, Mario Barbieri, Margherita Neri & Matteo Marti. (2018) Novel Synthetic Opioids: The Pathologist’s Point of View. Brain Sciences 8:9, pages 170.
Crossref
Anders Helander, Katarina Stojanovic, Tomas Villén & Olof Beck. (2018) Detectability of fentanyl and designer fentanyls in urine by 3 commercial fentanyl immunoassays. Drug Testing and Analysis 10:8, pages 1297-1304.
Crossref
Melissa M Goggin, Stephanie D Gozum, Anna Miller & Gregory C Janis. (2018) Anodyne by Design; Measuring the Prevalence of Esoteric Designer Opioids in Pain Management Patients. Journal of Analytical Toxicology 42:6, pages 384-391.
Crossref
Frank X. Scheuermeyer, Christopher DeWitt, Jim Christenson, Brian Grunau, Andrew Kestler, Eric Grafstein, Jane Buxton, David Barbic, Stefan Milanovic, Reza Torkjari, Indy Sahota & Grant Innes. (2018) Safety of a Brief Emergency Department Observation Protocol for Patients With Presumed Fentanyl Overdose. Annals of Emergency Medicine 72:1, pages 1-8.e1.
Crossref
Renata Solimini, Simona Pichini, Roberta Pacifici, Francesco P. Busardò & Raffaele Giorgetti. (2018) Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids. Frontiers in Pharmacology 9.
Crossref
Emilia Marchei, Roberta Pacifici, Giulio Mannocchi, Enrico Marinelli, Francesco Paolo Busardò & Simona Pichini. (2018) New synthetic opioids in biological and non-biological matrices: A review of current analytical methods. TrAC Trends in Analytical Chemistry 102, pages 1-15.
Crossref
Patil Armenian, Kathy T. Vo, Jill Barr-Walker & Kara L. Lynch. (2018) Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review. Neuropharmacology 134, pages 121-132.
Crossref
Alex J Krotulski, Donna M Papsun, Melissa Friscia, Jennifer L Swartz, Brian D Holsey & Barry K Logan. (2018) Fatality Following Ingestion of Tetrahydrofuranylfentanyl, U-49900 and Methoxy-Phencyclidine. Journal of Analytical Toxicology 42:3, pages e27-e32.
Crossref
Carolina Noble, Petur Weihe Dalsgaard, Sys Stybe Johansen & Kristian Linnet. (2017) Application of a screening method for fentanyl and its analogues using UHPLC‐QTOF‐MS with data‐independent acquisition (DIA) in MS E mode and retrospective analysis of authentic forensic blood samples . Drug Testing and Analysis 10:4, pages 651-662.
Crossref
Simona Pichini, Renata Solimini, Paolo Berretta, Roberta Pacifici & Francesco Paolo Busardò. (2018) Acute Intoxications and Fatalities From Illicit Fentanyl and Analogues: An Update. Therapeutic Drug Monitoring 40:1, pages 38-51.
Crossref
Rachael Rzasa Lynn & JL Galinkin. (2017) Naloxone dosage for opioid reversal: current evidence and clinical implications. Therapeutic Advances in Drug Safety 9:1, pages 63-88.
Crossref
Daniel C Butler, Kevin Shanks, George S Behonick, Dustin Smith, Susan E Presnell & Lee Marie Tormos. (2018) Three Cases of Fatal Acrylfentanyl Toxicity in the United States and a Review of Literature. Journal of Analytical Toxicology 42:1, pages e6-e11.
Crossref
Laura Hikin, Paul R. Smith, Eleanor Ringland, Simon Hudson & Stephen R. Morley. (2018) Multiple fatalities in the North of England associated with synthetic fentanyl analogue exposure: Detection and quantitation a case series from early 2017. Forensic Science International 282, pages 179-183.
Crossref
Hannah R. Fudin, Jennifer L. Babin, Lisa T. Hong, Jennifer Ku, Alisyn L. May, Alexander Wisner, F. Scott Hall & Sidhartha D. Ray. 2018. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 29 89 .
Nektaria Misailidi, Ioannis Papoutsis, Panagiota Nikolaou, Maria Katselou, Chara Spiliopoulou & Sotiris Athanaselis. (2017) Furanylfentanyl: another fentanyl analogue, another hazard for public health. Forensic Toxicology 36:1, pages 1-11.
Crossref
Michael Evans-Brown & Roumen Sedefov. 2018. New Psychoactive Substances. New Psychoactive Substances 3 49 .
Simon L. Hill & Paul I. Dargan. 2018. New Psychoactive Substances. New Psychoactive Substances 475 494 .
Anders Helander & Matilda Bäckberg. 2018. New Psychoactive Substances. New Psychoactive Substances 461 473 .
Robert Kronstrand, Davide Guerrieri, Svante Vikingsson, Ariane Wohlfarth & Henrik Gréen. 2018. New Psychoactive Substances. New Psychoactive Substances 495 541 .
Markus R. Meyer. 2018. New Psychoactive Substances. New Psychoactive Substances 441 459 .
Lea Wagmann & Hans H. Maurer. 2018. New Psychoactive Substances. New Psychoactive Substances 413 439 .
Brandon J. Warrick, Anita Paula Tataru & Roy Gerona. (2017) New Psychoactive Substances in Pediatric Patients. Pediatric Clinics of North America 64:6, pages 1223-1241.
Crossref
István Ujváry, Rita Jorge, Rachel Christie, Thomas Le Ruez, Helgi Valur Danielsson, Robert Kronstrand, Simon Elliott, Ana Gallegos, Roumen Sedefov & Michael Evans-Brown. (2017) Acryloylfentanyl, a recently emerged new psychoactive substance: a comprehensive review. Forensic Toxicology 35:2, pages 232-243.
Crossref
Jolanta B. Zawilska. (2017) An Expanding World of Novel Psychoactive Substances: Opioids. Frontiers in Psychiatry 8.
Crossref
Phillip Koshute, Nathan Hagan & N. Jordan Jameson. (2021) Machine Learning Models for Detecting Fentanyl Analogs from Mass Spectra. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.